118 related articles for article (PubMed ID: 6862311)
1. The clinical pharmacology of cytosine arabinoside.
Slevin ML; Piall EM; Aherne GW; Johnston A; Lister TA
Haematol Blood Transfus; 1983; 28():70-5. PubMed ID: 6862311
[No Abstract] [Full Text] [Related]
2. The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.
Slevin ML; Piall EM; Aherne GW; Johnston A; Sweatman MC; Lister TA
Br J Clin Pharmacol; 1981 Oct; 12(4):507-10. PubMed ID: 6945865
[TBL] [Abstract][Full Text] [Related]
3. [High dose cytosine arabinoside (HDCA) in children with refractory leukemia or malignant lymphoma (3 g/m2 vs 1.5 g/m2)].
Yumura K; Kawa K; Ishihara S; Hara J; Doi S; Tomita K; Yabuuchi H
Rinsho Ketsueki; 1985 Dec; 26(12):1979-85. PubMed ID: 3834163
[No Abstract] [Full Text] [Related]
4. [Cytosine arabinoside as a polyvalent drug in the treatment of acute non-lymphoid leukemias].
Sánchez Fayos J
Sangre (Barc); 1986; 31(5):566-73. PubMed ID: 3810411
[No Abstract] [Full Text] [Related]
5. Cytosine arabinoside (NSC-63878) given subcutaneously to patients with cancer.
Savel H; Burns SL
Cancer Chemother Rep; 1969 Apr; 53(2):153-6. PubMed ID: 5799419
[No Abstract] [Full Text] [Related]
6. Clinical pharmacology and human antitumor activity of cytosine arabinoside.
Talley RW; O'Bryan RM; Tucker WG; Loo RV
Cancer; 1967 May; 20(5):809-16. PubMed ID: 6071587
[No Abstract] [Full Text] [Related]
7. Cytarabine.
Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023
[No Abstract] [Full Text] [Related]
8. Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
Jones GR; Ettinger LJ
Semin Oncol; 1985 Jun; 12(2 Suppl 3):150-4. PubMed ID: 3874431
[No Abstract] [Full Text] [Related]
9. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
Furusawa S; Adachi Y; Nomura T; Komiya M
Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
[No Abstract] [Full Text] [Related]
10. Pharmacologic studies of tritiated cytosine arabinoside (NSC-63878) in children.
Finklestein JZ; Scher J; Karon M
Cancer Chemother Rep; 1970 Feb; 54(1):35-9. PubMed ID: 5538163
[No Abstract] [Full Text] [Related]
11. A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).
Burke PJ; Serpick AA; Carbone PP; Tarr N
Cancer Res; 1968 Feb; 28(2):274-9. PubMed ID: 4868015
[No Abstract] [Full Text] [Related]
12. Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia.
Howard JP; Albo V; Newton WA
Cancer; 1968 Mar; 21(3):341-5. PubMed ID: 5637945
[No Abstract] [Full Text] [Related]
13. Studies on the cytotoxicity of cytosine arabinoside.
Haanen C; Muus P; Raymakers R; Drenthe-Schonk A; Salden M; Wessels J
Semin Oncol; 1985 Jun; 12(2 Suppl 3):120-9. PubMed ID: 3892698
[No Abstract] [Full Text] [Related]
14. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
Hirano M; Morita A; Sako F; Uetani T; Koie K
Rinsho Ketsueki; 1972 Dec; 13(6):951-7. PubMed ID: 4675066
[No Abstract] [Full Text] [Related]
15. Central nervous system toxicity with high-dose cytosine arabinoside.
Herzig RH; Lazarus HM; Herzig GP; Coccia PF; Wolff SN
Semin Oncol; 1985 Jun; 12(2 Suppl 3):233-6. PubMed ID: 3892703
[No Abstract] [Full Text] [Related]
16. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
Ho DH; Frei E
Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
[No Abstract] [Full Text] [Related]
17. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Herzig RH; Coccia PF; Lazarus HM; Strandjord SE; Graham-Pole J; Cheung NK; Gordon EM; Gross S; Spitzer TR; Warkentin PI
Semin Oncol; 1985 Jun; 12(2 Suppl 3):184-6. PubMed ID: 3892700
[No Abstract] [Full Text] [Related]
18. [High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Suda K
Rinsho Ketsueki; 1985 Aug; 26(8):1258-64. PubMed ID: 3865002
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside.
Weinstein HJ; Griffin TW; Feeney J; Cohen HJ; Propper RD; Sallan SE
Blood; 1982 Jun; 59(6):1351-3. PubMed ID: 7082832
[TBL] [Abstract][Full Text] [Related]
20. Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
Buchanan JG
N Z Med J; 1971 Sep; 74(471):153-9. PubMed ID: 5289827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
